A Pilot Study Evaluating the Safety of Intravenously Administered Human Amnion Epithelial Cells for the Treatment of Hepatic Fibrosis

Liver cirrhosis is the 6th leading cause of death in adults aged 15–59 years in high-income countries. For many who progress to cirrhosis, the only prospect for survival is liver transplantation. While there is some indication that mesenchymal stem cells may be useful in reversing established liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Rebecca, Hodge, Alexander, Moore, Gregory, Wallace, Euan M., Sievert, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572339/
https://www.ncbi.nlm.nih.gov/pubmed/28878671
http://dx.doi.org/10.3389/fphar.2017.00549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572339/
https://www.ncbi.nlm.nih.gov/pubmed/28878671
http://dx.doi.org/10.3389/fphar.2017.00549

Ejemplares similares